sb 203580 has been researched along with luteolin-7-glucoside in 2 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (luteolin-7-glucoside) | Trials (luteolin-7-glucoside) | Recent Studies (post-2010) (luteolin-7-glucoside) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 241 | 0 | 152 |
Protein | Taxonomy | sb 203580 (IC50) | luteolin-7-glucoside (IC50) |
---|---|---|---|
Mitogen-activated protein kinase 10 | Homo sapiens (human) | 2.45 | |
Mitogen-activated protein kinase 14 | Homo sapiens (human) | 2.45 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bhutani, KK; Garg, D; Kadam, RU; Paul, AT; Roy, N | 1 |
Chen, MK; Chuang, YC; Hsieh, MJ; Lin, CC; Lin, JT; Lo, YS; Mahalakshmi, B; Velmurugan, BK | 1 |
2 other study(ies) available for sb 203580 and luteolin-7-glucoside
Article | Year |
---|---|
Evaluation of proinflammatory cytokine pathway inhibitors for p38 MAPK inhibitory potential.
Topics: Anti-Inflammatory Agents; Biflavonoids; Cytokines; Flavanones; Flavones; Flavonoids; Glucosides; Hydrogen Bonding; Imidazoles; Luteolin; Models, Molecular; p38 Mitogen-Activated Protein Kinases; Pyridines; Structure-Activity Relationship | 2007 |
Luteolin-7-O-Glucoside Inhibits Oral Cancer Cell Migration and Invasion by Regulating Matrix Metalloproteinase-2 Expression and Extracellular Signal-Regulated Kinase Pathway.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Enzyme Inhibitors; Flavones; Glucosides; Humans; Imidazoles; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Mouth Neoplasms; p38 Mitogen-Activated Protein Kinases; Pyridines | 2020 |